Jean W. Marstiller
Unternehmenssekretär bei CUMBERLAND PHARMACEUTICALS INC.
Profil
Jean W.
Marstiller is currently working as the Secretary & Senior VP-Administrative Services and Secretary & Senior Vice President at Cumberland Pharmaceuticals, Inc. since 2012.
Previously, Jean worked as the Director-Administrative Operations at Therapeutic Antibodies, Inc. from 1989 to 1998 and as a Principal at Brown-Forman Corp.
from 1982 to 1987.
Jean completed their undergraduate degree at Vanderbilt University.
Aktive Positionen von Jean W. Marstiller
| Unternehmen | Position | Beginn |
|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC. | Unternehmenssekretär | 06.01.1999 |
Ehemalige bekannte Positionen von Jean W. Marstiller
| Unternehmen | Position | Ende |
|---|---|---|
Therapeutic Antibodies, Inc.
 Therapeutic Antibodies, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Boston Scientific Corp., Therapeutic Antibodies, Inc. is a biopharmaceutical company that specializes in research and development to produce polyclonal antibodies. The company is based in Nashville, TN. Therapeutic Antibodies was acquired by Protherics Plc on September 15, 1999 for $38.46 million. | Verwaltungsdirektor | 01.01.1998 |
| BROWN-FORMAN CORPORATION | Corporate Officer/Principal | 01.01.1987 |
Ausbildung von Jean W. Marstiller
| Vanderbilt University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CUMBERLAND PHARMACEUTICALS INC. | Health Technology |
| BROWN-FORMAN CORPORATION | Consumer Non-Durables |
| Private Unternehmen | 1 |
|---|---|
Therapeutic Antibodies, Inc.
Therapeutic Antibodies, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Boston Scientific Corp., Therapeutic Antibodies, Inc. is a biopharmaceutical company that specializes in research and development to produce polyclonal antibodies. The company is based in Nashville, TN. Therapeutic Antibodies was acquired by Protherics Plc on September 15, 1999 for $38.46 million. | Commercial Services |
